Key Highlights
- Professor Kirsty Elliott-Sale urges female athletes to view egg freezing as just one component of a broader, well-funded reproductive healthcare package.
- Key medical and logistical challenges remain unresolved, including athletic downtime requirements, long-term storage and implantation costs, and non-guaranteed pregnancy outcomes.
- Because standard fertility stimulation medications are prohibited by the World Anti-Doping Agency (WADA), athletes must secure a Therapeutic Use Exemption (TUE) prior to treatment.
Fertility Support in Elite Sport: Progress Met with Practical Questions
The growing adoption of fertility benefits across elite women’s athletics has been widely celebrated as a pivotal advance for player welfare. However, leading specialists caution that current provisions raise significant medical, ethical, and logistical questions. Professor Kirsty Elliott-Sale, head of the Centre for Excellence for Women in Sport at Manchester Metropolitan University, has emphasized that while expanded reproductive care is a positive development, egg freezing must not be treated as a universal solution or a substitute for active career maternity support.
Expressing support for current initiatives, Elliott-Sale noted that she is delighted for any player who will benefit
from fertility programs. However, she advocates for a comprehensive approach where women are empowered to make informed family planning decisions at any stage of their sporting careers. Speaking to BBC Sport, she explained: Egg freezing is an opportunity which allows them to invest in their fertility journey – at this moment – for the future.
She continued: But we need to make sure that if they want to have children during their careers, that is an opportunity for them.
Addressing Guarantees, Funding Gaps, and Career Timing
A primary concern highlighted by Elliott-Sale is ensuring that clubs and sporting bodies do not prioritize cryopreservation over active maternity and pregnancy policies. She stressed that funding for ongoing fertility, pregnancy, and parental leave must match the investment directed toward freezing procedures, preventing scenarios where athletes face institutional pressure: Oh, but you froze your eggs…
Furthermore, medical realities must be clearly communicated to competitors considering the procedure. Egg freezing does not offer an absolute guarantee of a successful future pregnancy. Factors such as the total count and cellular quality of harvested eggs vary widely; harvested oocytes may not withstand the thawing process, and surviving eggs may fail to fertilize. Even when viable embryos successfully form, uterine implantation and full-term gestation cannot be assured.
Financial considerations also extend far beyond the initial medical retrieval. Pointing out the ambiguity surrounding downstream expenses, Elliott-Sale observed: It’s one thing to fund the freezing,
questioning whether clubs will also pay for their storage then the treatment needed to use them.
Athletic Downtime and Anti-Doping Regulatory Hurdles
In addition to financial and biological variables, there are notable unknowns regarding how fertility cycles integrate with rigorous training and competition schedules. One of the things that none of us know right now is how long you should take away from sport, if indeed you need to take any time away from sport to do this procedure,
Elliott-Sale stated, noting that empirical guidance on athletic recovery windows during ovarian stimulation remains sparse.
The process also introduces regulatory complexities under international sports governance. The medications required to stimulate the ovaries for egg production and subsequent retrieval feature on the World Anti-Doping Agency (WADA) prohibited list. To undergo the treatment legally without risking sanctions, athletes must formally declare the substances and secure a Therapeutic Use Exemption (TUE), which grants sanctioned clearance to utilize prohibited pharmaceuticals for a strictly defined medical timeframe.
Why This Matters
As elite sports organizations increasingly introduce reproductive benefits to attract and retain female talent, establishing clear framework standards is critical. Without comprehensive policies covering long-term storage fees, subsequent IVF procedures, and robust active-career maternity rights, egg freezing initiatives risk shifting the institutional responsibility of family accommodation into a delayed personal cost for the athlete. Addressing these biological limitations, funding uncertainties, and anti-doping protocols is essential for establishing sustainable, equitable welfare structures across professional leagues.
Frequently Asked Questions
Does freezing eggs guarantee that an athlete can have a baby later?
No. Egg freezing does not guarantee future motherhood. Collected egg quantities and quality vary significantly, some eggs fail to survive the thawing process, fertilization is not assured, and successful embryo implantation and full-term pregnancy are never guaranteed.
Are fertility medications allowed under World Anti-Doping Agency rules?
The fertility drugs utilized to stimulate ovaries for egg retrieval are prohibited under the World Anti-Doping Agency (WADA) code. Competitors must declare their usage and obtain an approved Therapeutic Use Exemption (TUE) prior to treatment to avoid anti-doping violations.
What secondary costs remain a question for sports clubs funding the procedure?
While an organization may cover the upfront cost of the egg retrieval and freezing procedure, questions remain over whether contracts will cover recurring annual cryostorage fees or the subsequent medical treatments required to fertilize, culture, and transfer embryos in the future.
